Letermovir for cytomegalovirus prophylaxis in lung transplant recipients: A promising shift toward reduced myelotoxicity.

Alsharif, Muath; Pennington, Kelly M

Alsharif, Muath; Pennington, Kelly M.

Affiliation

Alsharif M; Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Pennington KM; Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Transpl Infect Dis ; 26(3): e14277, 2024 Jun.

Article in En | MEDLINE | ID: mdl-38742608

Subject(s)

Acetates; Antiviral Agents; Cytomegalovirus Infections; Lung Transplantation; Quinazolines; Humans; Cytomegalovirus Infections/prevention & control; Lung Transplantation/adverse effects; Antiviral Agents/therapeutic use; Antiviral Agents/adverse effects; Acetates/therapeutic use; Acetates/adverse effects; Acetates/administration & dosage; Quinazolines/therapeutic use; Quinazolines/adverse effects; Cytomegalovirus/drug effects; Triazoles/therapeutic use; Triazoles/adverse effects; Triazoles/administration & dosage; Transplant Recipients

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Quinazolines / Lung Transplantation / Cytomegalovirus Infections / Acetates Limits: Humans Language: En Journal: Transpl Infect Dis Journal subject: TRANSPLANTE Year: 2024 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google